# FDA Inspection 1246994 - Tianjin Kingyork Pharmaceuticals Co., Ltd - July 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/tianjin-kingyork-pharmaceuticals-co-ltd/05774bd5-a7e4-4adb-8eee-aebeedea48d3
Source feed: FDA_Inspections

> FDA Inspection 1246994 for Tianjin Kingyork Pharmaceuticals Co., Ltd on July 26, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246994
- Company Name: Tianjin Kingyork Pharmaceuticals Co., Ltd
- Inspection Date: 2024-07-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1095299 - 2019-05-31](https://www.keypedia.com/records/fda_inspections/tianjin-kingyork-pharmaceuticals-co-ltd/ae2dd3e9-8782-4dc8-9440-6b55923d0f92)
- [FDA Inspection 986374 - 2016-09-01](https://www.keypedia.com/records/fda_inspections/tianjin-kingyork-pharmaceuticals-co-ltd/b54178d0-6906-4197-863a-1070ef78b648)
- [FDA Inspection 854753 - 2013-07-05](https://www.keypedia.com/records/fda_inspections/tianjin-kingyork-pharmaceuticals-co-ltd/54e834e6-6023-4989-b33a-715c0b0f8137)

Company: https://www.keypedia.com/companies/tianjin-kingyork-pharmaceuticals-co-ltd/f9a09d47-f6b9-4654-8d4d-dc81f001b5a7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c